(TheNewswire)
London, ON – TheNewswire - March 23 2021 – TroyMedia Corp. i s Canad a’slatest Media leader to be draw n to SernovaCorp.’s (TSXV:SVA) (OTC:SEOVF) story and developments.
TroyMedia wasfounded in 2005 and since then has become the largest independentprovider of original feature and analysis in Canada. Content distributed by TroyMedia appears in Canadian newspapers andnews sites daily.
Its content is alsoreceived by more than 1,300 working journalists, who either republishit or use it as a basis for their own research. Newspapers that havecarr ied its content include TheGlobe and Mail , National Post , andall the major Postmedia and Sun outlets.
Sernova’ s news c overage was BusinessFront-Page Thursday March 18 th in thefollowing publications, with the headline:
“A Canadian Path to a Regenerative Cure to Type 1 Diabetes”
Troy Media
MicroNews.ca
Edmonton'sBusiness
CamroseVoice
KindersleyClarion
West-CentralCrossroads
StrathmoreVoice
IngersollVoice
Kirkland LakeVoice
PembrokeVoice
KapuskasingVoice
NorwichVoice
Camrose Voice ( see "Business")
Rosetown Eagle("Business")
PortageCitizen ("Business")
NelsonVoice
WarmanVoice
Rockyford Voice (Click "Business"upper left)
Fort MacKay Voice (Click "Business"upper left)
HussarVoice
BluenoseBulletin
Sask ValleyVoice
EtobicokeVoice
Grande Cache Voice
Sernova followers and stakeholder are encouraged to share the followingcoverage via their own Social Media feeds.
Additional, new media interest is forthcoming and all interestedparties are invited to Bookmark Sernova’s website orsubscribe to the company’s Twitter , YouTube and LinkedIn channels.
About Sernova Corp.
Sernova isdeveloping regenerative medicine therapeutic technologies using amedical device and immune protected therapeutic cells (i.e. humandonor cells, corrected human cells, and stem cell-derived cells) toimprove the treatment and qu ality of life of people with chronicmetabolic diseases such as insulin-dependent diabetes, blood disordersincluding hemophilia, and other diseases treated through replacementof proteins or hormones missing or in short supply within the body.For more information, please visit www.sernova.com .
FOR FURTHER INFORMATION, PLEASE CONTACT:
Dominic Gray
Sernova Corp
T: (519) 858-5126
dominic.gray@sernova.com
Neither TSX Venture Exchange nor its Regulation Services Provider (asthat term is defined in policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this press release.
Cautionary Statement Regarding Forward-Looking Information
This press release contains ‘forward-looking information’ withinthe meaning of applicable Canadian securities legislation. Thesestatements relate to future events or future performance. The use ofany of the words “could”, “intend”, “expect”,“believe”, “will”, “projected”, “estimated” andsimilar expressions and statements relating to matters that are nothistorical facts are intended to identify forward-looking informationand are based on Sernova’s current belief or assumptions as to theoutcome and timing of such future events. Forward looking informationin this press release includes information with respect to theintended use of proceeds by the Company. Forward-looking informationis based on reasonable assumptions that have been made by Sernova atthe date of the information and is subject to known and unknown risks,uncertainties, and other factors that may cause actual results orevents to differ materially from those anticipated in theforward-looking information. Examples of such risk factors include:credit; market (including equity, foreign exchange and interest rate);liquidity; operational (including technology and infrastructure);reputational; insurance; strategic; regulatory; legal; environmental;capital adequacy; the general business and economic conditions in theregions in which the Company operates; the ability of the Company toexecute on key priorities, including the successful development of itsproduct candidates, and strategic plans and to attract, develop andretain key executives; the ability to implement business strategiesand pursue business opportunities; disruptions in or attacks(including cyber-attacks) on the Company's information technology; thefailure of third parties to comply with their obligations to theCompany or its affiliates; the impact of new and changes to, orapplication of, current laws and regulations governing the Company’sbusiness; dependence on key suppliers; granting of permits andlicenses; increased competition; changes in foreign currency rates;increased funding costs and market volatility due to marketilliquidity and competition for funding; the availability of funds andresources to pursue operations; critical accounting estimates andchanges to accounting standards, policies, and methods used by theCompany; the occurrence of natural and unnatural catastrophic eventsand claims resulting from such events; risks related to COVID-19including various recommendations, orders and measures of governmentalauthorities to try to limit the pandemic, including travelrestrictions, border closures, nonessential business closures,quarantines, self-isolations, shelters-in-place and social distancing,disruptions to markets, economic activity, financing, supply chainsand sales channels, and a deterioration of general economic conditionsincluding a possible national or global recession; as well as thoserisk factors disclosed under the heading “Risk Factors” in theCompany’s Annual Information Form (dated February 8, 2021) for theyear ended October 31, 2020, which has been filed on SEDAR and isavailable under the Company’s profile at www.sedar.com. Given theserisks, uncertainties and assumptions, you should not unduly rely onthese forward-looking statements. The forward-looking informationcontained in this press release is made as of the date hereof, andSernova is not obligated to update or revise any forward-lookinginformation, whether as a result of new information, future events orotherwise, except as required by applicable securities laws. Theforegoing statements expressly qualify any forward-looking informationcontained herein.
Copyright (c) 2021 TheNewswire - All rights reserved.